Study data showed 57% of evaluable patients (N=23) had a partial response and 4% achieved a complete response. Among the 14 responders, 64% did not have significant tumor growths for ≥6 months.
Tafinlar + Mekinist Approved for BRAF-Positive Anaplastic Thyroid Cancer posted first on https://www.youtube.com/dailyhealthpost/
No comments:
Post a Comment